Post IPO Highlights (Sep, 23 – Sep, 29)

Foremost Lithium Shifts Focus to Uranium, Partners with Denison

Foremost Clean Energy Ltd. (FMST)

Foremost Lithium is changing its name to Foremost Clean Energy and entering the uranium exploration business through a major deal with Denison Mines. Foremost will acquire up to a 70% interest in 10 of Denison’s uranium projects in Saskatchewan’s Athabasca Basin, a prime location for uranium deposits. This deal gives Foremost access to over 330,000 acres of exploration land, some of which is near existing uranium mines.

This partnership will allow Foremost to leverage Denison’s expertise in uranium exploration and development. Denison’s President and CEO, David Cates, will join Foremost’s board, further solidifying the collaboration. Foremost will now focus on exploring these uranium properties, aiming to capitalize on the increasing global demand for clean energy and the crucial role of nuclear power in achieving decarbonization goals.

Kairos Pharma and PreCheck Health to Develop Biomarkers for Cancer Treatment

Kairos Pharma, Ltd. (KAPA)

Kairos Pharma, a clinical-stage biopharmaceutical company, has partnered with PreCheck Health Services, a genetic sequencing lab, to develop biomarkers for Kairos Pharma’s cancer therapy, ENV105. This treatment targets drug-resistant prostate and lung cancers.

The collaboration aims to improve patient selection for ENV105 clinical trials by identifying those most likely to benefit. PreCheck will analyze patient biopsies and circulating tumor cells to validate existing biomarkers and discover new ones. This will involve using PreCheck’s SolidTumorCheck+ platform for gene expression profiling.

The ultimate goal is to develop a companion diagnostic test for ENV105, which would help personalize cancer treatment by ensuring that the therapy is administered only to patients who are likely to respond positively. This precision medicine approach could significantly improve outcomes for patients with resistant forms of prostate and lung cancer.

Icon Energy Expands Fleet and Secures New Loan Facility

Icon Energy Corp (ICON)

Icon Energy, a global shipping company, has taken delivery of a new dry bulk carrier, the M/V Bravo, and secured a term loan facility for up to $91.5 million. The M/V Bravo has already been chartered to a commodity trading company for 11 to 14 months.

Icon used $16.5 million of the loan to finance part of the M/V Bravo’s purchase and leverage its existing vessel, the M/V Alfa. The remaining $75 million is available for future vessel acquisitions, supporting Icon’s growth strategy. This move highlights Icon’s commitment to expanding its fleet and strengthening its position in the global shipping market.

Membership